Oasmia Pharmaceutical has named Anette Sjödin as Executive Vice President as of June 1, 2019 and Maria Nilsson Hagberg as Head of Regulatory Affairs as of April 18, 2019.
Mikael Asp, CEO of Oasmia said in the press release that the company gladly adds Sjödin and Hagberg to the team, pointing out their established track record of success in their respective positions.
“Anette’s knowledge and global experience will be a great benefit to augment international commercialization and further establish Oasmia’s current business position. Maria’s many years of experience in Regulatory Affairs will facilitate the work surrounding submissions to the FDA regarding the US and other markets,” Asp said.